Digital Health Startups

Incentive Incubator is a seed-stage incubator in Israel that screens early-stage companies and provides support through a network of business, technology, and strategic experts. The organization operates as the seed arm of Peregrine Ventures and co-invests with other venture capital firms.

1 investor

First Stop Health provides virtual healthcare for employees through employer-sponsored plans, offering primary care, urgent care, and mental health services at no cost to members and their dependents. Its care teams include board-certified doctors, dietitians, health coaches, and licensed therapists delivering whole-person virtual care via phone, video, web, and mobile app.

1 investor

Inclusivity Solutions builds innovative business models and risk management solutions, with a focus on improving access to insurance products in emerging markets. The company serves microinsurance customers and insurance institutions in developing regions.

1 investor

Indegene provides technology-enabled commercial solutions and consulting services for life sciences and healthcare enterprises, helping them optimize customer experiences, content management, and data-driven decision-making across their commercial operations.

1 investor

Impartial Medical Experts (IME) is a consulting firm with a telehealth software application that connects clients with screened medical and surgical specialists for independent expert opinions. It serves lawyers, insurance companies, hospitals, doctors, patients, and medical device companies, providing medical litigation support and usability evaluations of medical products and devices.

1 investor

IndiAide provides a Remote Therapeutic Monitoring (RTM) platform used by private practices and outpatient clinics to bridge the gap between therapy sessions and patient progress at home. Aimed at speech-language pathologists and similar clinicians, the platform supports therapy adherence to improve patient outcomes and clinic revenue.

1 investor

Indigo is developing an implantable continuous multi-metabolite monitoring (CMM) sensor based on silicon photonics that measures metabolites such as glucose, ketone, and lactate in real time, with data shown via a smartphone app. The device targets chronic disease management, initially diabetes, with potential applications in chronic kidney disease, oncology, cardiovascular disease, and athletic performance.

1 investor

Indira IVF provides in-vitro fertilization treatment services across a network of clinics in India, focused on increasing awareness and accessibility of fertility treatments. The company operates through standardized clinical protocols and trained gynecologists to deliver consistent outcomes across its clinics.

1 investor

IndiTreat is a CE IVD-marked functional drug sensitivity test that uses patient-derived tumor organoids to guide personalized treatment decisions for metastatic colorectal cancer (mCRC) patients. It is aimed at healthcare professionals and oncologists as a complement to traditional biomarker testing.

1 investor

Indivi is a medical technology company developing tools for precision and personalised medicine in neuroscience research and development, including Bring Your Own Device (BYOD) technology. It collaborates with RC2NB to characterise disease processes and support personalised disease management for people affected by MS and other neuroimmune and neurodegenerative diseases.

1 investor

InductiveHealth provides disease surveillance systems to federal, state, tribal, local, and territorial public health jurisdictions. The company combines epidemiologists and public health experts with engineers and technologists to deliver scalable public health technology solutions.

1 investor

Infius Health manufactures in-vitro diagnostic kits that automate manual medical testing procedures. The company serves healthcare providers and laboratories requiring diagnostic solutions.

1 investor

Healthgrades operates an online platform that helps patients find and choose doctors and specialists based on experience, hospital affiliation, patient reviews, insurance, and other criteria. It also publishes educational content, appointment guides, and patient stories covering a wide range of medical conditions and procedures.

1 investor

InformDx (Inform Diagnostics) provides subspecialty anatomic pathology laboratory services, working directly with clinicians to deliver diagnostic testing and results for patient diagnoses. Its offerings cover gastrointestinal pathology, dermatopathology, urologic pathology, hematopathology, breast pathology, and COVID-19 testing, primarily serving physicians and medical practices in the United States.

1 investor

InformedDNA applies genetics expertise and technology to deliver genomics insights and services such as telegenetic counseling for payors, healthcare providers, and patients across the US. It operates in the digital health and genomics space, supporting clinical decisions around screening, diagnosis, and treatment.

1 investor

Informedic provides a compliant application that uses machine learning to summarize medical records and automate underwriting decisions for life insurance. It targets life insurance underwriting teams seeking faster and lower-cost medical record review.

1 investor

Informuta provides predictive infection intelligence tools that forecast antibiotic resistance risk to help clinicians prevent treatment failures and optimize antibiotic prescribing decisions. The company serves healthcare providers and infectious disease practitioners with AI-driven diagnostics and bacterial evolutionary analytics.

1 investor

InfuCare Rx provides specialized infusion therapies and medications, supported by an interdisciplinary team of healthcare professionals. The company offers personalized therapy programs and patient education to improve health outcomes.

1 investor

In Full Health is an initiative and learning-and-action community that promotes centering equity in health innovation investment, development, and purchasing, encouraging resources for solutions built with and for historically marginalized communities in the U.S. It provides a shared framework and convenes stakeholders committed to advancing health equity.

1 investor

Infusion Innovations develops medical devices and intelligent systems for home infusion therapies, serving healthcare providers in Australia/New Zealand, North America, and Europe. The company addresses complex health conditions including rheumatology, gastrointestinal disorders, infectious diseases, cancer, and immune deficiencies through condition-specific technologies, clinical management tools, and data analytics.

1 investor

InGeno develops personalized genetic tests based on DNA analysis, providing individuals with information about their predispositions related to nutrition, sports, health, skin, and hair. Customers order a test online, receive a home collection kit, and get a report with the option to consult an expert.

1 investor

InHandPlus develops a wrist-worn camera and IMU device embedded in a watch to capture hand and activity data. The company operates two businesses: a healthcare platform deployed with Korean hospitals and welfare centers, and licensed physical AI datasets for robotics teams training dexterous hand manipulation.

1 investor

INHERET provides an online tool that collects detailed family health histories and evaluates hereditary cancer risk, then links to best-practice guidelines so providers can recommend next steps. It serves individuals and healthcare providers to identify, understand, and manage risks of hereditary conditions such as colon, breast, ovarian, pancreatic, and prostate cancers.

1 investor

RDi Evolve (formerly Inicio) develops digital healthcare solutions including AI/ML for clinical applications, intelligent automation, and diagnostics tools designed for healthcare systems and providers. The company specializes in interoperability platforms, EHR enhancements, and automation to improve clinical workflows and patient outcomes.

1 investor